JOHNS HOPKINS UNIVERSITY

🇳🇦Namibia

Country: 🇳🇦Namibia

Ownership: -

Established: 1876-01-01

Employees: 19.4K

Market Cap: -

Website: https://www.jhu.edu/

Clinical Trials

Vitreous Surgery With Intraocular Assistance

Not Applicable

Terminated

Conditions: Traction Retinal Detachments
Rhegmatogenous Retinal Detachments
Dislocated Intraocular Lens

Interventions: Procedure: Intraocular assistance

First Posted Date: 2015-10-14

Last Posted Date: 2017-09-26

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 5

Registration Number: NCT02574624

Locations: 🇺🇸
Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States

Answer ALS: Individualized Initiative for ALS Discovery

Completed

Conditions: Progressive Muscular Atrophy
Flail Arm ALS
Healthy Controls
Motor Neuron Disease
Amyotrophic Lateral Sclerosis
Monomelic Amyotrophy
Asymptomatic ALS Gene Carriers
Primary Lateral Sclerosis

First Posted Date: 2015-10-12

Last Posted Date: 2020-01-13

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 1049

Registration Number: NCT02574390

Locations: 🇺🇸
Texas Neurology, Dallas, Texas, United States
🇺🇸
Cedars-Sinai Medical Center, Los Angeles, California, United States
🇺🇸
Emory University, Atlanta, Georgia, United States

and more 5 locations

CHWs, mHealth, and Combination HIV Prevention

Not Applicable

Completed

Conditions: HIV

Interventions: Behavioral: HealthScouts
Other: Standard of Care

First Posted Date: 2015-09-22

Last Posted Date: 2020-08-31

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 3773

Registration Number: NCT02556957

Locations: 🇺🇬
Rakai Health Sciences Program, Entebee, Uganda

Assessment of the Tolerability of Dry Airflow in the Nasal Cavity During Sleep

Not Applicable

Withdrawn

Conditions: Healthy Adults

Interventions: Device: Nasal High Flow

First Posted Date: 2015-09-11

Last Posted Date: 2017-08-08

Lead Sponsor: Johns Hopkins University

Registration Number: NCT02547688

Locations: 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States

Epidemiology and Treatment of Small-colony Variant Staphylococcus Aureus in Cystic Fibrosis

Phase 4

Withdrawn

Conditions: Cystic Fibrosis
MRSA

Interventions: Drug: Rifampin

First Posted Date: 2015-09-11

Last Posted Date: 2021-01-14

Lead Sponsor: Johns Hopkins University

Registration Number: NCT02547116

Locations: 🇺🇸
Johns Hopkins University School of Medicine, Baltimore, Maryland, United States

tDCS and Cognition in Adults With Multiple Sclerosis or Encephalitis

Not Applicable

Completed

Conditions: Encephalitis
Multiple Sclerosis

Interventions: Device: Sham Transcranial direct current stimulation
Device: Anodal Transcranial direct current stimulation

First Posted Date: 2015-09-02

Last Posted Date: 2020-04-06

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 7

Registration Number: NCT02538094

Locations: 🇺🇸
Johns Hopkins East Baltimore Campus; Medical Psychiatry department, Baltimore, Maryland, United States

Effect of Supplementation of Fluoride on Maternal Periodontal Health, Preterm Delivery, and Perinatal Well-Being

Early Phase 1

Completed

Conditions: Preterm Labor
Preterm Birth
Bacteremia
Preterm Premature Rupture of Fetal Membranes

Interventions: Drug: Prenatal vitamin-mineral containing 3 mg fluoride
Dietary Supplement: Prenatal vitamin-mineral containing 0 mg fluoride

First Posted Date: 2015-08-31

Last Posted Date: 2019-11-05

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 43

Registration Number: NCT02536352

Locations: 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States

Evaluation of Effect of CryoBalloon Focal Ablation System on Human Esophageal Epithelium

Not Applicable

Completed

Conditions: Barrett's Esophagus
Esophageal Squamous Dysplasia
Esophageal Cancer

Interventions: Device: CryoBalloon

First Posted Date: 2015-08-27

Last Posted Date: 2025-05-11

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 53

Registration Number: NCT02534233

Locations: 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States

Evaluating Muscle Weakness Improvement With Lorcaserin in ICU

Phase 1

Terminated

Conditions: Muscle Weakness
Sepsis

Interventions: Drug: Lorcaserin
Drug: Placebo

First Posted Date: 2015-08-14

Last Posted Date: 2020-01-13

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 5

Registration Number: NCT02523690

Locations: 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States

Screening for TB in Pregnancy. on HIV-Infected Pregnant Women

Not Applicable

Completed

Conditions: Tuberculosis

Interventions: Other: Sputum sample

First Posted Date: 2015-08-13

Last Posted Date: 2017-08-18

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 1400

Registration Number: NCT02520973

Locations: 🇿🇦
Perinatal HIV Research Unit, Klerksdorp, Northwest, South Africa

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy